{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:00:57Z","timestamp":1784977257077,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["NO.22DZ1202304"],"award-info":[{"award-number":["NO.22DZ1202304"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04230-x","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T11:32:17Z","timestamp":1770809537000},"page":"3228-3243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment of insulin resistance-related ten-gene signature in endometrial cancer and identification of ACTL8 as a prognostic and immunological biomarker"],"prefix":"10.1007","volume":"28","author":[{"given":"Siyun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoXiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0284-819X","authenticated-orcid":false,"given":"Jinlong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"1","key":"4230_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4230_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"issue":"3","key":"4230_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4230_CR4","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4230_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","volume":"7","author":"V Makker","year":"2021","unstructured":"Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN, Aoki D, et al. Endometrial cancer. Nat Rev Dis Primers. 2021;7(1):88.","journal-title":"Nat Rev Dis Primers"},{"key":"4230_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13866","author":"M Koskas","year":"2021","unstructured":"Koskas M, Amant F, Mirza MR, Creutzberg CL. Cancer of the corpus uteri: 2021 update. Int J Gynaecol Obstet. 2021. https:\/\/doi.org\/10.1002\/ijgo.13866.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4230_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15\u201337.","journal-title":"Diabetes Metab J"},{"key":"4230_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4230_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):3000605231164548.","journal-title":"J Int Med Res"},{"key":"4230_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770.","journal-title":"Metabolism"},{"issue":"2","key":"4230_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ijc.22697","volume":"121","author":"M Jenab","year":"2007","unstructured":"Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, Nieters A, et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition. Int J Cancer. 2007;121(2):368\u201376.","journal-title":"Int J Cancer"},{"issue":"7","key":"4230_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1158\/1055-9965.EPI-12-0310","volume":"21","author":"UA Hvidtfeldt","year":"2012","unstructured":"Hvidtfeldt UA, Gunter MJ, Lange T, Chlebowski RT, Lane D, Farhat GN, et al. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer. Cancer Epidemiol Biomark Prev. 2012;21(7):1203\u201312.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"4230_CR13","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/1940-6207.CAPR-16-0141","volume":"9","author":"E Loftfield","year":"2016","unstructured":"Loftfield E, Freedman ND, Lai GY, Weinstein SJ, McGlynn KA, Taylor PR, et al. Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes. Cancer Prev Res (Phila). 2016;9(11):866\u201374.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"8","key":"4230_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/aje\/kws309","volume":"177","author":"L Dossus","year":"2013","unstructured":"Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S, et al. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. Am J Epidemiol. 2013;177(8):787\u201399.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"4230_CR15","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.7314\/APJCP.2015.16.12.4987","volume":"16","author":"S Otokozawa","year":"2015","unstructured":"Otokozawa S, Tanaka R, Akasaka H, Ito E, Asakura S, Ohnishi H, et al. Associations of serum isoflavone, adiponectin and insulin levels with risk for epithelial ovarian cancer: results of a case-control study. Asian Pac J Cancer Prev. 2015;16(12):4987\u201391.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4230_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.755341","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Gao C, Cao F, Wu Y, Chen S, Han X, et al. Pan-cancer analysis of IGF-1 and IGF-1R as potential prognostic biomarkers and immunotherapy targets. Front Oncol. 2021;11:755341.","journal-title":"Front Oncol"},{"issue":"18","key":"4230_CR17","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.ejca.2015.08.031","volume":"51","author":"AV Hernandez","year":"2015","unstructured":"Hernandez AV, Pasupuleti V, Benites-Zapata VA, Thota P, Deshpande A, Perez-Lopez FR. Insulin resistance and endometrial cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2015;51(18):2747\u201358.","journal-title":"Eur J Cancer"},{"issue":"2","key":"4230_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00404-018-5006-z","volume":"299","author":"SG Vitale","year":"2019","unstructured":"Vitale SG, Capriglione S, Zito G, Lopez S, Gulino FA, Di Guardo F, et al. Management of endometrial, ovarian and cervical cancer in the elderly: current approach to a challenging condition. Arch Gynecol Obstet. 2019;299(2):299\u2013315.","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"4230_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-019-0177-x","volume":"19","author":"ME Urick","year":"2019","unstructured":"Urick ME, Bell DW. Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 2019;19(9):510\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4230_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","volume":"17","author":"MJ Gunter","year":"2008","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(4):921\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"4230_CR21","first-page":"2173","volume":"15","author":"Y Lai","year":"2018","unstructured":"Lai Y, Sun C. Association of abnormal glucose metabolism and insulin resistance in patients with atypical and typical endometrial cancer. Oncol Lett. 2018;15(2):2173\u20138.","journal-title":"Oncol Lett"},{"key":"4230_CR22","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.2147\/IJWH.S500936","volume":"16","author":"S Gao","year":"2024","unstructured":"Gao S, Wang J, Wang T, Wang J. Is insulin resistance a high-risk factor for postmenopausal endometrial cancer: insights from the triglyceride glucose (TyG) index and the metabolic score for insulin resistance (METS-IR). Int J Womens Health. 2024;16:2355\u201363.","journal-title":"Int J Womens Health"},{"issue":"4","key":"4230_CR23","doi-asserted-by":"publisher","first-page":"355.e1","DOI":"10.1016\/j.ajog.2010.11.033","volume":"204","author":"JK Burzawa","year":"2011","unstructured":"Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, et al. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol. 2011;204(4):355.e1-7.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"4230_CR24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/cam4.1391","volume":"7","author":"N Mu","year":"2018","unstructured":"Mu N, Dong M, Liu C, Wang X, Cong J, Wang L, et al. Association between preoperative serum insulin levels and lymph node metastasis in endometrial cancer-a prospective cohort study. Cancer Med. 2018;7(4):1519\u201327.","journal-title":"Cancer Med"},{"issue":"4","key":"4230_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1158\/1055-9965.EPI-20-1613","volume":"30","author":"MA Merritt","year":"2021","unstructured":"Merritt MA, Strickler HD, Hutson AD, Einstein MH, Rohan TE, Xue X, et al. Sex hormones, insulin, and insulin-like growth factors in recurrence of high-stage endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(4):719\u201326.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4230_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9060632","author":"S Rousset-Rouviere","year":"2021","unstructured":"Rousset-Rouviere S, Rochigneux P, Chr\u00e9tien AS, Fattori S, Gorvel L, Provansal M, et al. Endometrial carcinoma: immune microenvironment and emerging treatments in immuno-oncology. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9060632.","journal-title":"Biomedicines"},{"issue":"7447","key":"4230_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373.","journal-title":"Nature"},{"issue":"2","key":"4230_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, McConechy MK, Leung S, Li-Chang HH, Kwon JS, Melnyk N, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113(2):299\u2013310.","journal-title":"Br J Cancer"},{"issue":"10","key":"4230_CR29","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1007\/s10620-024-08649-6","volume":"69","author":"W Yu","year":"2024","unstructured":"Yu W, Zhang Q, Ali M, Chen B, Sun Q, Wang D. ACTL8 promotes the progression of gastric cancer through PI3K\/AKT\/mTOR signaling pathway. Dig Dis Sci. 2024;69(10):3786\u201398.","journal-title":"Dig Dis Sci"},{"key":"4230_CR30","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/OTT.S185858","volume":"12","author":"Q Han","year":"2019","unstructured":"Han Q, Sun ML, Liu WS, Zhao HS, Jiang LY, Yu ZJ, et al. Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer. Onco Targets Ther. 2019;12:1749\u201363.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"4230_CR31","first-page":"877","volume":"19","author":"B Li","year":"2019","unstructured":"Li B, Zhu J, Meng L. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Mol Med Rep. 2019;19(2):877\u201384.","journal-title":"Mol Med Rep"},{"key":"4230_CR32","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.2147\/OTT.S291403","volume":"14","author":"S Fan","year":"2021","unstructured":"Fan S, Yan S, Yang Y, Shang J, Hao M. Actin-like protein 8 promotes the progression of triple-negative breast cancer via activating PI3K\/AKT\/mTOR pathway. OncoTargets Ther. 2021;14:2463\u201373.","journal-title":"OncoTargets Ther"},{"issue":"3","key":"4230_CR33","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/1759-7714.13247","volume":"11","author":"S Ma","year":"2020","unstructured":"Ma S, Wang X, Zhang Z, Liu D. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Thorac Cancer. 2020;11(3):526\u201336.","journal-title":"Thorac Cancer"},{"issue":"8","key":"4230_CR34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41568-018-0023-6","volume":"18","author":"H Liu","year":"2018","unstructured":"Liu H, Kiseleva AA, Golemis EA. Ciliary signalling in cancer. Nat Rev Cancer. 2018;18(8):511\u201324.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"4230_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.devcel.2013.07.014","volume":"26","author":"C Yeh","year":"2013","unstructured":"Yeh C, Li A, Chuang JZ, Saito M, C\u00e1ceres A, Sung CH. IGF-1 activates a cilium-localized noncanonical G\u03b2\u03b3 signaling pathway that regulates cell-cycle progression. Dev Cell. 2013;26(4):358\u201368.","journal-title":"Dev Cell"},{"issue":"3","key":"4230_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1101\/gad.2008011","volume":"25","author":"JB Wallingford","year":"2011","unstructured":"Wallingford JB, Mitchell B. Strange as it may seem: the many links between Wnt signaling, planar cell polarity, and cilia. Genes Dev. 2011;25(3):201\u201313.","journal-title":"Genes Dev"},{"issue":"6","key":"4230_CR37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/ncb2259","volume":"13","author":"MA Lancaster","year":"2011","unstructured":"Lancaster MA, Schroth J, Gleeson JG. Subcellular spatial regulation of canonical Wnt signalling at the primary cilium. Nat Cell Biol. 2011;13(6):700\u20137.","journal-title":"Nat Cell Biol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04230-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04230-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:28:56Z","timestamp":1784975336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04230-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["4230"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04230-x","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No financial conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research followed the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}